Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells

FASEB Journal

Volumn 14, Issue 14, 2000, Pages 2221-2229

  Goepfert, T M ^a   Mccarthy, M ^b   Kittrell, F S ^a   Stephens, C ^c   Ullrich, R L ^b   Brinkley, B R ^a   Medina, D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Aneuploidy; Centrosomes; Estrogen; Steroid hormone

Indexed keywords

ESTROGEN; PROGESTERONE; PROTEIN P53;

ANEUPLOIDY; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CENTROSOME; CHROMOSOME; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0033746030     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0165com     Document Type: Article

References (59)

1. Preneoplasia in mammary tumorigenesis
2. The comparative pathology of human and mouse mammary glands
3. Biologic and genetic features of in situ breast cancer
4. Biological features of human premalignant breast disease
5. Analysis of chromosome aneuploidy in breast cancer progression using fluorescence in situ hybridization
6. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci
7. Comparative allelotypes of in situ and invasive human breast cancer: High frequency of micro-satellite instability in lobular breast carcinomas
8. Pathological and biological relevance of cytophotometric DNA content to breast carcinoma genetic progression
9. Biological characteristics of premalignant and preinvasive breast disease
10. A comparison of the salient features of mouse, rat and human mammary tumorigenesis
11. Clustering of aberrations on specific chromosomes in human neoplasms. A survey of 1871 cases
12. Chemically-induced aneuploidy in mammalian cells: Mechanisms and biological significance in cancer
13. Aneuploidy and consistent structural chromosome changes associated with transformation of Syrian hamster embryo cells
14. The mitotic machinery as a source of genetic instability in cancer
15. How aneuploidy affects metabolic control and causes cancer
16. Genetic instabilities in human cancers
17. Supernumerary centrosomes and cancer; Boveri's hypothesis resurrected
18. The complexity of p53 modulation: Emerging patterns from divergent signals
19. The p53 pathway
20. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
21. The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model
22. Abnormal centrosome amplification in the absence of p53
23. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis
24. A p53-dependent mouse spindle checkpoint
25. Centrosome defects and genetic instability in malignant tumors
26. Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity
27. Tumour amplified kinase STK15/BRAK induces centrosome amplification, aneuploidy and transformation
28. Altered centrosome structure is associated with abnormal mitoses in human breast tumors
29. Delayed involution of the mammary epithelium in BALB/c-p53 null mice
30. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
31. Control of mammary gland development
32. Mammary gland development and tumorigenesis in estrogen receptor knockout mice
33. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
34. Roles of estrogen and progesterone in normal mammary gland development
35. Progesterone stimulates DNA synthesis and lobuloalveolar development in mammary glands in ovariectomized mice
36. Antiprogestins inhibit growth and stimulate differentiation in the normal mammary gland
37. The effects of oestrogens and progesterone on the chemical induction of mammary cancer in mice of the IF strain
38. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function
39. The antiprogestin RU38 486: Receptor mediated progestin versus antiprogestin actions screened in estrogen insensitive T47D human breast cancer cells
40. Steroid receptor mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells
41. Effects of estrogen and estrogen-progestin on mammographic parenchymal density
42. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
43. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
44. The mammary gland: A unique organ for the study of development and tumorigenesis
45. Kinetics of mammary epithelial cell proliferation in pituitary isografted BALB/c mice
46. Hormonal prevention of breast cancer: Mimicking the protective effect of pregnancy
47. Development of mammary preneoplasias in vivo from mouse mammary epithelial cells in vitro
48. Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats
49. Radiation-induced apoptosis in normal and preneoplastic mammary glands in vivo: Significance of gland differentiation and p53 status
50. Progesterone receptors in the mouse mammary duct: Distribution and developmental regulation
51. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen treated virgin female BALB/c mice
52. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media
53. Radiation-induced chromosomal instability in Balb/c and C57B1/6 mice: The difference is as clear as black and white
54. Genomic instability and apoptosis are frequent in p53 deficient young mice
55. Continuous mouse mammary tumor cell lines and clonal derivatives: Comparison of growth properties in vitro and transplantability in vivo
56. Cellular and molecular mechanisms of multistep carcinogenesis in cell culture models
57. Fluorescent light-induced DNA crosslinkage and chromatid breaks in mouse cells in culture
58. Enhanced proliferative potential in culture of cells from p53-deficient mice
59. Genetic instability in colorectal cancers